Markedly Improved Glycemic Control and Enhanced Insulin Sensitivity in a Patient with Type 2 Diabetes Complicated by a Suprasellar Tumor Treated with Pioglitazone and Metformin
-
- IGAKI Naoya
- Department of Internal Medicine, Takasago Municipal Hospital
-
- TANAKA Maki
- Department of Internal Medicine, Takasago Municipal Hospital
-
- GOTO Takeo
- Department of Internal Medicine, Takasago Municipal Hospital
この論文をさがす
抄録
A patient with type 2 diabetes and hypothalamic damage due to a suprasellar tumor developed impaired glycemic control and central obesity. The patient showed exaggerated adrenocorticotropic hormone responsiveness as determined by a corticotrophin releasing hormone test and elevated serum leptin concentrations associated with ravenous appetite and insulin resistance mediated in part through disturbances in leptin signaling. Combination treatment with metformin and pioglitazone was markedly effective in improving glycemic control. Additionally, metformin treatment showed marked anorectic effects on the hyperphagia. This case has important implications for the pathogenesis and management of diabetes in patients with hypothalamic-pituitary-adrenal axis deficiencies.
収録刊行物
-
- Internal Medicine
-
Internal Medicine 44 (8), 832-837, 2005
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679846172800
-
- NII論文ID
- 130000076345
-
- NII書誌ID
- AA10827774
-
- ISSN
- 13497235
- 09182918
-
- NDL書誌ID
- 7402181
-
- PubMed
- 16157982
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可